PubMed · 5648885
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
C T Wehby. 1968. Wallet hip.. https://pubmed.ncbi.nlm.nih.gov/5648885/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
An extensive survey has been designed to provide detailed information on carbon monoxide (CO) concentration in the main transport modes and along heavy traffic routes in the Athens urban area. Specifically the study identifies the main factors affecting CO exposure during commuting. Several portable, electrochemical CO monitors (Solomat's MPM4100), were used to record the in-vehicle CO concentrations every 15 s. Measurements were performed during rush hour periods. Field monitoring was conducted in summer 1998 and winter 1998-1999. Exposure estimates were compared to WHO guidelines. The findings showed that the mean CO level over trips of 30 min was 21.4 ppm for private car against 10.4, 9.6, 4 and 11.5 ppm for bus, trolley, electric train and pedestrians, respectively. Transport mode, route, monitoring period and season had a significant influence on the measured CO concentrations. The study points out the importance of microenvironmental monitoring, instead of using fixed-site data in assessing commuter's CO exposure.
Every physician providing care to diabetics will at some time be asked whether driving is allowed. The answer is often determined by the type of sequela that may develop, in particular diabetic retinopathy. Among the metabolic conditions, hypoglycemia is important. But the fitness of a diabetic to drive may be impaired more by such associated conditions as CHD or hypertension than by the diabetes as possible to drive, near-normal glucose levels and intensive counseling are necessary, to ensure not only that the patient can carry out the required control measures, and self-medicate, but also is able to recognize threatening hypoglycemia in good time. Good documentation of the physician's surveillance is the basis for the determination of fitness to drive by an independent expert.
In this study, forensic cases involving the use of Gamma Hydroxy Butyric acid (GHB) from the second half of 1999 through the second half of 2001 in The Netherlands (blood >5mg/l and urine >10mg/l) are described. GHB was analysed by GC-MS after lactone formation and using GHB-d6 as internal standard. The results are divided into three groups: cases of chemical submission, cases of driving under the influence and cases of unknown causes of death.GHB was found in six cases of possible chemical submission. In these cases, relatively low concentrations of GHB were found. The results show that in cases of chemical submission, urine should be analyzed, because GHB is present longer in urine than in blood. The police should collect the samples in containers that do not contain citrate as anticoagulant. Especially at low levels of GHB, the formation of GHB in these tubes hampers an interpretation of the results.GHB was found in 13 cases of driving under the influence. In contrast to the cases of chemical submission, high concentrations of GHB were found, corresponding with observations of extreme sleepiness or temporary loss of consciousness.GHB was found in 16 cases of unexplained death: the measured range of GHB concentrations in blood might correspond to effects such as drowsiness, but not to serious toxicity of GHB. In 4 of these 16 cases, the role of GHB could be excluded. In the remaining cases, the role of GHB remains unclear; more research into "background" concentrations of GHB in post-mortem material is required. The incidence of the use of GHB in The Netherlands cannot be derived from these toxicological data. As GHB is not routinely found during systematical toxicological analyses, these data may seriously underestimate the use of GHB. Therefore, information from the police to the forensic institute is essential.